相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and clinical characteristics of sleep-disordered breathing in patients with heart failure of different left ventricular ejection fractions
Tao Wang et al.
SLEEP AND BREATHING (2023)
Sleep apnoea and heart failure
Patrick Levy et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Sleep apnoea and ischaemic stroke: current knowledge and future directions
Sebastien Baillieul et al.
LANCET NEUROLOGY (2022)
Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes
Vera Certikova Chabova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Relationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Yumeng Wang et al.
MEDICAL SCIENCE MONITOR (2022)
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
Husam M. Salah et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
Vincenzo Maria Monda et al.
ADVANCES IN THERAPY (2021)
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Yerem Yeghiazarians et al.
CIRCULATION (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Female Patients With Sleep-Disordered Breathing Display More Frequently Heart Failure With Preserved Ejection Fraction
Simon Lebek et al.
FRONTIERS IN MEDICINE (2021)
Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction
John E. Sanderson et al.
HEART (2021)
Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease
Milton Packer
AMERICAN JOURNAL OF MEDICINE (2020)
Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms
Claire Arnaud et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2020)
Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management
Liann Abu Salman et al.
CURRENT CARDIOLOGY REPORTS (2020)
Heart Failure with Preserved Ejection Fraction-a Concise Review
Daria M. Adamczak et al.
CURRENT CARDIOLOGY REPORTS (2020)
Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction
Alexandria Miller et al.
SCIENTIFIC REPORTS (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Profile of sleep disordered breathing in heart failure with preserved ejection fraction
Nitesh Gupta et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2020)
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial
Ian J. Neeland et al.
DIABETES CARE (2020)
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
Masanori Shimizu et al.
DIABETES OBESITY & METABOLISM (2019)
Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications
A. J. Scheen
DIABETES & METABOLISM (2019)
Heart Failure With Preserved Ejection Fraction In Perspective
Marc A. Pfeffer et al.
CIRCULATION RESEARCH (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiac amyloidosis: An underdiagnosed/underappreciated disease
Antonis S. Manolis et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea
Hong Sang Choi et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)
Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes
Peili Wu et al.
HORMONE AND METABOLIC RESEARCH (2019)
Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice
Kazuno Omori et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
Omar A. Mesarwi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study
Yi Tang et al.
NUTRITION & DIABETES (2019)
Sex differences in heart failure
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2019)
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
Henith Raj et al.
WORLD JOURNAL OF DIABETES (2019)
Relation of Obstructive Sleep Apnea to Risk of Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction from the National Inpatient Sample
Abdullah Abdullah et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Monika Rech et al.
CARDIOVASCULAR RESEARCH (2018)
Counterpoint to the hypothesis that SGLT2 inhibitors protect the heart by antagonizing leptin
Angelo Avogaro et al.
DIABETES OBESITY & METABOLISM (2018)
Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis
Milton Packer
DIABETES OBESITY & METABOLISM (2018)
Leptin and Leptin Resistance in the Pathogenesis of Obstructive Sleep Apnea: A Possible Link to Oxidative Stress and Cardiovascular Complications
Slava Berger et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
The Relationship between Diabetes-Related Complications and Obstructive Sleep Apnea in Type 2 Diabetes
Nantaporn Siwasaranond et al.
JOURNAL OF DIABETES RESEARCH (2018)
Efficacy of canagliflozin against nonalcoholic fatty liver disease: a prospective cohort study
Toshio Itani et al.
OBESITY SCIENCE & PRACTICE (2018)
Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
Dug-Hyun Choi et al.
ENDOCRINOLOGY AND METABOLISM (2018)
Obstructive sleep apnea and chronic kidney disease
Chou-Han Lin et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline
Vishesh K. Kapur et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
Shusuke Yagi et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction
Erin D. Unger et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses
Hidekatsu Fukuta et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: A ten-year follow-up study
Jae-Seung Yun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?
Bisher Abuyassin et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2015)
Prevalence and Associated Factors of Obstructive Sleep Apnea in Patients with Resistant Hypertension
Elizabeth S. Muxfeldt et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
International Classification of Sleep Disorders-Third Edition Highlights and Modifications
Michael J. Sateia
CHEST (2014)
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
J. Bolinder et al.
DIABETES OBESITY & METABOLISM (2014)
Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study
Abd A. Tahrani et al.
DIABETOLOGIA (2014)
SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats
Masanori Yokono et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction
Robert J. Mentz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Leptin: A biomarker for sleep disorders?
Weihong Pan et al.
SLEEP MEDICINE REVIEWS (2014)
Association of Epicardial Adipose Tissue With Progression of Coronary Artery Calcification Is More Pronounced in the Early Phase of Atherosclerosis Results From the Heinz Nixdorf Recall Study
Amir A. Mahabadi et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models
M. Suzuki et al.
NUTRITION & DIABETES (2014)
Epicardial Adipose Tissue Volume and Adipocytokine Imbalance Are Strongly Linked to Human Coronary Atherosclerosis
Michio Shimabukuro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Obstructive Sleep Apnea A Cardiometabolic Risk in Obesity and the Metabolic Syndrome
Luciano F. Drager et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Sleep Disturbances as Nontraditional Risk Factors for Development and Progression of CKD: Review of the Evidence
Nicolas F. Turek et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Obstructive sleep apnea syndrome
Massimo R. Mannarino et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
Jan Bolinder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models
Yin Liang et al.
PLOS ONE (2012)
American heart Association/American college of cardiology Foundation/Heart rhythm society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death - A scientific statement from the American Heart Association council on clinical cardiology committee on electrocardiography and arrhythmias and council on epidemiology and prevention
Jeffrey J. Goldberger et al.
CIRCULATION (2008)
Sleep-disordered breathing and type 2 diabetes - A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention
Jonathan E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Epidemiology of obstructive sleep apnea: a population-based perspective
Won Lee et al.
Expert Review of Respiratory Medicine (2008)
Obstructive sleep apnea is associated with increased urinary albumin excretion
Michael D. Faulx et al.
SLEEP (2007)
Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients:: A prospective study
Pauline Jouet et al.
OBESITY SURGERY (2007)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2006)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
分享论文
